Catdoc Limited 07652152 false 2023-05-01 2024-04-30 2024-04-30 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true 07652152 2023-05-01 2024-04-30 07652152 2024-04-30 07652152 bus:OrdinaryShareClass1 2024-04-30 07652152 core:CurrentFinancialInstruments 2024-04-30 07652152 bus:SmallEntities 2023-05-01 2024-04-30 07652152 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 07652152 bus:FullAccounts 2023-05-01 2024-04-30 07652152 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 07652152 bus:RegisteredOffice 2023-05-01 2024-04-30 07652152 bus:Director1 2023-05-01 2024-04-30 07652152 bus:OrdinaryShareClass1 2023-05-01 2024-04-30 07652152 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 07652152 countries:England 2023-05-01 2024-04-30 07652152 2022-05-01 2023-04-30 07652152 2023-04-30 07652152 bus:OrdinaryShareClass1 2023-04-30 07652152 core:CurrentFinancialInstruments 2023-04-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 07652152

Prepared for the registrar

Catdoc Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 April 2024

 

Catdoc Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 4

 

Catdoc Limited

Company Information

Director

Dr J R Campbell

Registered office

The London Cat Clinic
82-86 Spa Road
Bermondsey
London
England
SE16 3QT

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

Catdoc Limited

(Registration number: 07652152)
Balance Sheet as at 30 April 2024

Note

2024
£

2023
£

Current assets

 

Debtors

4

1

1

Capital and reserves

 

Called up share capital

5

1

1

Shareholders' funds

 

1

1

For the financial year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 2 August 2024
 


Dr J R Campbell
Director

 

Catdoc Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

 

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
The London Cat Clinic
82-86 Spa Road
Bermondsey
London
England
SE16 3QT

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Catdoc Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2023 - 0).

 

4

Debtors

2024
 £

2023
 £

Other debtors

1

1

 

1

1

 

5

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary shares of £1 each

1

1

1

1